Dec 9 (Reuters) - Revance Therapeutics ( RVNC ):
* CROWN LABORATORIES AND REVANCE ENTER INTO AMENDED AND
RESTATED
MERGER AGREEMENT
* REVANCE THERAPEUTICS INC ( RVNC ): CROWN WILL COMMENCE A TENDER
OFFER TO
ACQUIRE ALL OUTSTANDING SHARES OF REVANCE'S COMMON STOCK FOR
$3.10 PER SHARE IN CASH
* REVANCE THERAPEUTICS INC ( RVNC ): WILL COMMENCE A TENDER OFFER TO
ACQUIRE ALL OUTSTANDING SHARES OF REVANCE'S COMMON STOCK FOR
$3.10 PER SHARE IN CASH
Source text:
Further company coverage: